Skip to main navigation Skip to search Skip to main content

Cancer-ID: towards identification of cancer by tumor-derived extracellular vesicles in blood

  • L G Rikkert
  • , P Beekman
  • , J Caro
  • , F A W Coumans
  • , A Enciso Martinez
  • , G Jenster
  • , S Le Gac
  • , W Lee
  • , Ton G Van Leeuwen
  • , G B Loozen
  • , A Nanou
  • , R Nieuwland
  • , H L Offerhaus
  • , C Otto
  • , D M Pegtel
  • , M C Piontek
  • , E Van Der Pol
  • , L De Rond
  • , W H Roos
  • , R B M Schasfoort
  • Marca Wauben, H Zuilhof, Leon WMM Terstappen

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Extracellular Vesicles (EVs) have great potential as biomarkers since their composition and concentration in biofluids are disease state-dependent and their cargo can contain disease related information. Large tumor-derived EVs (tdEVs, > 1 μm) in blood from cancer patients are associated with poor outcome and changes in their number can be used to monitor therapy effectiveness. Whereas small tumor-derived EVs (
Original languageEnglish
Article number608
Number of pages19
JournalFrontiers in Oncology
Volume10
DOIs
Publication statusPublished - Jun 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Atomic Force Microscopy
  • Cell-Derived Microparticles
  • Electrochemistry
  • Exosomes
  • Flow Cytometry
  • Raman spectrum analysis
  • Scanning electron microscopy
  • Surface Plasmon Resonance
  • extracellular vesicles
  • fluorescence microscopy
  • transmission electron microscopy 3

Fingerprint

Dive into the research topics of 'Cancer-ID: towards identification of cancer by tumor-derived extracellular vesicles in blood'. Together they form a unique fingerprint.

Cite this